ProCE Banner Series

Addressing Treatment Challenges in Growth Hormone Deficiency With Novel Long-Acting Therapies

Join us for a live hybrid event where leading experts will provide insight and tools for endocrinology specialists to address the treatment challenges in growth hormone deficiency. Esteemed faculty will discuss the available and emerging treatment options in pediatric and adult patients as well as providing insights in overcoming challenges with long-term GHD management.

In-person attendees must register for the event on ENDO's website:

http://www.xpressreg.net/register/endo0623/landing.asp

To claim credit, please use the link below which is hosted on ENDO's website:

https://education.endocrine.org/URL/ENDO23_GHD

  AAPA
  | ANCC
  | AMA
Who Should Attend

This program is intended for adult and pediatric endocrinology specialists (MDs, NPs, PAs), primary care/family medicine providers (MDs, NPs, PAs), scientists, researchers, and other healthcare professionals who manage adult and pediatric patients with growth hormone deficiency.

All Events

Addressing Treatment Challenges in Growth Hormone Deficiency With Novel Long-Acting Therapies

Past Events

June

15

2023

7:30 PM - 9:00 PM Central Time (CT)

In-personVirtual

Faculty

ProCE Banner Faculty
Sara Divall, MD

Associate Professor, Pediatrics
Center for Clinical and Translational Research
Endocrinology Fellowship Director
Seattle Children’s Endocrinology
University of Washington Medicine
Seattle, Washington

ProCE Banner Faculty
Andrew Hoffman, MD

Professor of Medicine
Stanford University School of Medicine
Stanford, California

ProCE Banner Faculty
Laurence Katznelson, MD

Professor of Medicine (Endocrinology) and Neurosurgery
Associate Dean of Graduate Medical Education
Medical Director, Pituitary Center
Stanford Health Care, Stanford School of Medicine
Stanford, California

Topics

- Overview of adult and pediatric GHD

- Overview of available and emerging GH treatment options in pediatric and adult patients

- Overcoming challenges with long-term GHD management

- Conclusion/QNA

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act 
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact meetings@clinicaloptions.com prior to the live event.

CME/CE Info

Goal Statement
The goal of this program is to improve the knowledge and competence of learners to improve the timely diagnosis and optimize treatment for patients with growth hormone deficiency. 

Target Audience
This program is intended for adult and pediatric endocrinology specialists (MDs, NPs, PAs), primary care/family medicine providers (MDs, NPs, PAs), scientists, researchers, and other healthcare professionals who manage adult and pediatric patients with growth hormone deficiency. 

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Apply the appropriate diagnostic tests to a patient with a high suspicion of GHD
  • Evaluate the efficacy and safety of long-acting growth hormone therapies in pediatric and adult patients with GHD
  • Develop comprehensive treatment plans for patients with GHD, including agent selection, dosing, and monitoring
  • Implement strategies to improve treatment adherence and transitions of care for patients with GHD

Accreditation

The Endocrine Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The Endocrine Society has achieved Accreditation with Commendation.

AMA PRA Category 1 Credit

The Endocrine Society designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Please note that while other accrediting bodies accept AMA PRA Category 1 credit, we can only award and report this credit for MDs/DOs. For those outside of this accreditation, please complete the participation evaluation and use that certificate as proof of attendance to submit to your accrediting body.

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Nursing Continuing Professional Development
The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1.5 contact hours.

Physician Assistant/Physician Associate Continuing Medical Education

Clinical Care Options, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credits for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.5 AAPA Category 1 CME credits. PAs should only claim commensurate with the extent of their participation.

Disclosure of Conflicts of Interest 
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company. 

Acknowledgement

Jointly provided by Clinical Care Options, LLC and Endocrine Society.

This activity is supported by an educational grant from Novo Nordisk.